openPR Logo
Press release

Key Opinion Leaders to Present at the Respiratory Drug Delivery Conference

08-16-2019 11:37 AM CET | Health & Medicine

Press release from: SMi Group

Respiratory Drug Delivery

Respiratory Drug Delivery

SMi Reports: Learn from key opinion leaders at the Respiratory Drug Delivery conference this December

SMi Group are delighted to announce their inaugural conference Respiratory Drug Delivery, taking place on 5th – 6th December 2019 in London, UK.

The conference aims to bring together clinical researchers, respiratory drug manufacturers and solution providers to discuss the current research and developments in providing appropriate long-term treatments that adhere to patient’s needs, analysing the success of digital medical devices and connective health technology in aiding the diagnosis of severe asthma and COPD.

This year, attendees will have the opportunity to network and learn from key opinion leaders including:

Dr Alison Moore, Clinical Development Manager, GSK

Ph.D Gunilla Petersson, Science and Innovation Director, Astrazeneca

Mr Herbert Wachtel, Senior Principal Scientist, Boehringer Ingelheim

Mr Mark Milton-Edwards, Head of Product & Health Solutions, Digital Health, Teva Pharmaceuticals

Dr Orla Ni Ogain, Pharmaceutical Assessor, Medicines & Healthcare products Regulatory Agency (MHRA)

Professor Tim Higenbottam, President of the Faculty of Pharmaceutical Medicine, Faculty of Pharmaceutical Medicine

Mr Mayur Patel, Leading innovative medical and combination product development, PA Consulting
Dr Dave Lewis, Aerosol Science Director, Chiesi Ltd

Professor Chris Corrigan, Professor of Asthma, Allergy and Immunology, Kings College London

Dr Jorge Bernardino de la Serna, Senior Lecturer, Inhalation, Toxicology and Pharmacology, Imperial College London

Ms Aljoscha Koenneke, PhD Pharmacist, Institute of Biopharmaceutics and Pharmaceutical Technology, Saarland University

The final brochure, with the full agenda and speaker line-up, is available to download online at http://www.respiratorydrugdelivery.com/openpr4

Plus, key conference highlights for 2019 include:
• Hear updates from pharmaceutical companies on assessing the strategies to transform disease management through drug combinations, devices and inhaled biologic treatments
• Discuss the issues associated within pricing pressure of Asthma and COPD inhalation products
• Explore the current novel technologies and therapeutics aimed to optimize the delivery of respiratory drugs such as nanoparticle-based drug delivery
• Gain insight into the strategies being implemented to digital connective inhalation to improve patient adherence

For those interested in attending the conference, an early bird sale of £300 is available for bookings made before 30th September. Registrations can be made online at http://www.respiratorydrugdelivery.com/openpr4

Respiratory Drug Delivery
5th – 6th December 2019
Copthorne Tara Hotel, London, UK

For delegate enquiries please contact Fateja Begum on +44 (0) 20 7827 6184 or fbegum@smi-online.co.uk

For sponsorship enquiries please contact Alia Malick on +44 (0) 207 827 6168 or amalick@smi-online.co.uk

India House, 45 Curlew Street,
London, SE1 2ND

About SMi Group: Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward-thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Key Opinion Leaders to Present at the Respiratory Drug Delivery Conference here

News-ID: 1822930 • Views: 108

More Releases from SMi Group

Registration is now open for the Pre-filled Syringes and Injectable devices Conf …
SMi Reports: Registration is open for SMi Group’s 12th annual conference and exhibition taking place in January 2020 in London. As Europe’s leading Pre-Filled Syringes conference, the 2020 event will assess innovations in device engineering and components, enhancement of human factors, and optimizing packaging and containment. With the rapid expansion of the PFS market, the regulatory environment is more importance than ever. This year’s programme will look at the EU MDR,
Fresenius Kabi to Deliver Two Spotlight Sessions at SMi’s Pharmaceutical Manuf …
SMi Reports: Inaugural conference set to explore contamination control in pharmaceutical aseptic manufacturing using cleanroom and barrier technologies this October The inaugural Pharmaceutical Manufacturing and Cleanroom Technology conference is set to commence on 9th and 10th October 2019 in London, UK. The conference will feature key opinion leaders from all areas of the pharmaceutical, biological and cleanroom industry to explore the current topics within cleanroom design and engineering, best practices and
Key Case Studies will be Presented at SMi’s Benelux Infrastructure Forum 2019 …
SMi Reports: Case study updates from Van Oord, BESIX Group, Rebel and Macquarie to be delivered at the Benelux conference this November The 18th Annual Benelux Infrastructure Forum, taking place on 20th – 21st November in Amsterdam, will feature key professionals in the PPP, project financing and infrastructure sectors who will discuss the latest issues and trends within the Benelux market. One of the key benefits for this year’s conference
Chief Executive of DE&S to Brief on Safe Delivery of UK Defence Equipment Progra …
SMi Report: Sir Simon Bollom, Chief Executive, DE&S UK MoD, to deliver a keynote presentation at the 2019 Defence Safety conference, this October in London Conference organisers, SMi Group, are pleased to announce that the Chief Executive of Defence Equipment and Support (DE&S), Sir Simon Bollom, will once again, be delivering a keynote address at the second annual Defence Safety conference, taking place on 7th and 8th October in London. Sir

All 5 Releases


More Releases for Respiratory

Global Respiratory Protection Equipment Market Research Report
This report studies the global Respiratory Protection Equipment market status and forecast, categorizes the global Respiratory Protection Equipment market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia). The major manufacturers covered in this report 3M Avon Protection Systems Bullard Group Honeywell International MSA Safety Alpha Pro Tech Ansell
Respiratory Inhalers Market - Global Industry Analysis 2025
Chronic respiratory diseases are the group of chronic diseases which affect airways, lungs and the other parts of respiratory system. Chronic respiratory disease include asthma and respiratory allergies, Chronic Obstructive Pulmonary Disease (COPD), Occupational Lung Diseases, Sleep Apnoea Syndrome and Pulmonary Hypertension. However 70% chronic respiratory disease are asthma and chronic obstructive pulmonary disease. In 2012, globally, 1 billion people are affected with chronic respiratory disease and account for 7%
Respiratory Monitoring Devices Industry Trends
Global Respiratory Monitoring Devices Market: Snapshot Factors at the forefront of driving the demand in the global respiratory monitoring devices market are the rising number of cigarette smokers and a worsening air quality on account of rampant pollution. Further, a burgeoning geriatric population highly susceptible to lung diseases has also pushed up the demand in the market. Countering its growth, however, are the steep prices of newer, sophisticated respiratory monitoring devices,
Respiratory Monitoring Devices Market 2015
While a handful players have taken up a majority share in the global distribution of respiratory monitoring devices, the remainder of the market is marked by a very large number of small players. Of the key multinationals dominating the distribution of respiratory monitoring devices in 2014, CareFusion Corporation, Smiths Medical, and ResMed, Inc., had garnered a total share of 54.2% in terms of value. As described in a research report released
5th Global Respiratory and Pulmonologist Annual Meeting
Pulmonology » | Pulmonology Conference » | Respiratory Congress » | Pulmonologists Meeting » | COPD Conference » On behalf of the Conference Organizing Committee, it is with great pleasure that we welcome you to the official website of 5th Global Respiratory and Pulmonologist Annual Meeting during November 17-18, 2016 at Dubai, UAE. Conference Theme: Optimizing Research strategies & Neoteric developments in Pulmonary Disorders Respiratory disorders is a medical terminology which includes
Respiratory Distress in Premature Infants
FOR IMMEDIATE RELEASE New York, NY:Respiratory distress syndrome (RDS) is a breathing condition common in premature infants whose lungs have not fully developed yet. The earlier the birth in gestational time, the more prone the infant is to RDS and the more severe it is likely to be. Fully developed lungs are coated with a naturally occurring slippery substance called surfactant. Surfactant lines the air sacs in the lungs and reduces surface